Antiemetic Drugs Compatibility Evaluation with Paediatric Parenteral Nutrition Admixtures
نویسندگان
چکیده
Chemotherapy-induced nausea and vomiting are defined as the most common of side effects treatment and, at same time, very difficult to accept for patients’, frequently causing changes in therapy regimen, significantly reducing its effectiveness. Thus, an antiemetic prophylactic is essential provision such a patient. Pharmacotherapy often includes various drugs, including antiemetics, with administration drugs by injection through two separate catheters being preferred method. However, co-administration parenteral nutrition admixtures (PNAs) requires consideration compatibility, stability potential negative interactions. To meet purposes clinical pharmacy, compatibility test ondansetron, dexamethasone hydrocortisone paediatric PNAs was conducted. differ composition amino acid source (Primene® or Aminoplasmal Paed® 10%) type injectable lipid emulsion (Lipidem® 200 mg/mL, Clinoleic® 20%, SMOFlipid® Intralipid® 20%). An vitro evaluation performed static way simulated Y-site. The drug PNA ratios were determined based on extreme infusion rates contained characteristics medicinal products. All calculations hypothetical patient aged 7 years weighing 24 kg. As result this study, it can be concluded that all tested showed required range parameters pH, osmolality, turbidity, zeta potential, MDD homogeneity. does not adversely affect stability. This combination consistently compatible during period.
منابع مشابه
Compatibility: drugs and parenteral nutrition
OBJECTIVE Standardization and systematization of data to provide quick access to compatibility of leading injectable drugs used in hospitals for parenteral nutrition. METHODS We selected 55 injectable drugs analyzed individually with two types of parenteral nutrition: 2-in-1 and 3-in-1. The following variables were considered: active ingredient, compatibility of drugs with the parenteral nutr...
متن کاملCompatibility and stability of additives in parenteral nutrition admixtures.
The addition of additives (electrolytes, trace elements, and vitamins) to parenteral nutrition (PN) mixtures can lead to precipitation as a result of physical incompatibilities and can lead to chemical degradation of individual ingredients. The most significant cause of precipitation is excessive concentrations of calcium phosphate. The most significant cause of chemical instability is the oxid...
متن کاملCompatibility of intravenous medications with parenteral nutrition: in vitro evaluation.
BACKGROUND AND AIM Hospitalized patients requiring parenteral nutrition (PN) often need to receive intravenous (IV) medications as well. Y-site administration is occasionally necessary, but physicochemical incompatibilities can occur between the medications and PN. The aim of the present study was to assess the physical compatibility between 25 frequently coadministered IV medications and a com...
متن کاملCalculating aluminum content in total parenteral nutrition admixtures.
MARYBETH DRISCOLL, B.S.PHARM., is Staff Pharmacist, Parenteral Admixture Compounding Facility, Department of Pharmacy, B. I. Deaconess Medical Center (BIDMC), Boston, MA. DAVID F. DRISCOLL, PH.D., is Assistant Professor of Medicine, Harvard Medical School, and Senior Researcher, Nutrition/Infection Laboratory, Department of Medicine, BIDMC. Calculating aluminum content in total parenteral nutri...
متن کاملPhysicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice.
BACKGROUND Parenteral antiepileptic drugs are frequently used in critically ill patients for seizure control therapy or prevention. Many of these patients require additional parenteral nutrition (PN). Therefore, a parallel infusion of the frequently used antiepileptic drug levetiracetam (LEV) is interesting in terms of the restricted i.v. lines (e.g., neonates). The potential interactions of th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmaceutics
سال: 2023
ISSN: ['1999-4923']
DOI: https://doi.org/10.3390/pharmaceutics15082143